Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans

M A Creager1, J P Cooke, M E Mendelsohn

  • 1Division of Vascular Medicine and Atherosclerosis, Brigham and Women's Hospital, Boston, Massachusetts 02115.

Insights

High cholesterol (hypercholesterolemia) impairs blood vessel function in humans. This study found reduced vasodilator responses to endothelium-derived relaxing factor and nitrovasodilators in hypercholesterolemic individuals.

Area of Science:

  • Cardiovascular Physiology
  • Metabolic Disorders

Background:

  • Hypercholesterolemia is a significant risk factor for cardiovascular disease.
  • Understanding its direct impact on vascular function, independent of atherosclerosis, is crucial.

Purpose of the Study:

  • To investigate the effect of hypercholesterolemia on vascular reactivity in human forearm resistance vessels.
  • To assess the roles of endothelium-derived relaxant factor and direct smooth muscle stimulation in hypercholesterolemia.

Main Methods:

  • Vascular reactivity was measured in normal and hypercholesterolemic subjects using forearm venous occlusion plethysmography.
  • Intrabrachial artery infusions of methacholine and nitroprusside were administered to assess vasodilation.
  • Phenylephrine infusion was used to examine vasoconstrictive responsiveness.

Main Results:

  • Basal and reactive hyperemia blood flow were comparable between groups.
  • Hypercholesterolemic subjects showed blunted forearm blood flow responses to both methacholine and nitroprusside.
  • Vasoconstrictive response to phenylephrine was not different between groups.

Conclusions:

  • Hypercholesterolemia impairs vasodilator function in human forearm resistance vessels.
  • This impairment affects both endothelium-dependent (endothelium-derived relaxant factor) and endothelium-independent (nitrovasodilator) pathways.
  • Reduced vasodilator response in hypercholesterolemia may contribute to endothelial dysfunction.

Related Concept Videos

Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Vascular Resistance01:20

Vascular Resistance

Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...